recommended reading

FDA fielding app to track drug side effects during emergencies

Martina Kalaba/Newscom

This story has been updated.

The Food and Drug Administration is building a surveillance app for clinicians and regulators to monitor patients having bad reactions to experimental drugs administered during public health crises, agency officials said.

The so-called Real-Time Application for Portable Interactive Devices, or RAPID, will collect videos and images of patient reactions, such as skin lesions, as well as sound recordings of medical histories. And the app will be able to display geographic trends in effects by tracking the Global Positioning System locations of users. The system first will be tested on a small number of smartphone users and later tried out on tablet computers, including iPads, according to a notice posted Wednesday on the government buying website FedBizOpps.

FDA plans to contract with a software developer that can produce a fully operational prototype within one year and a strategy for fielding the app nationwide, the solicitation stated. The tool must be compatible with iPhones, Android-based phones and BlackBerry devices -- in that order of priority, according to the announcement.

There is not yet a timetable for hiring a company or for nationwide rollout. "It is still very early in the acquisition process," FDA spokeswoman Patricia El-Hinnawy said. "This solicitation is a first step to gauge if vendors are able to do this type of work." Vendor input is due on Jan. 18. After receiving responses, the agency "will be in a position to provide more definitive information" on when the product will be available, she said.

Agency officials expect the app will solve a problem discovered during the 2009 pandemic flu outbreak. In that crisis situation, FDA regulators had no up-to-date information on the effects of an investigational drug, Peramivir, which was dispensed under a special emergency authority. The existing monitoring system, called Medwatch, could transmit reports of adverse reactions by phone, fax, snail mail or e-mail only if an emergency worker could find a computer. The upshot: about 10 percent of bad reactions to drugs are not reported, according to federal auditors.

FDA officials realized an app would make possible portable, instantaneous reporting -- as well as allow officials to reciprocate by broadcasting immediate warnings and directions to clinicians.

That two-way communication would be an improvement over the existing method of issuing press releases directing doctors and patients to go to FDA.gov, which "is time-consuming, costly, burdensome and late to implement in crisis situations," FDA officials said.

By harnessing GPS data on users' phones, for the first time, regulators will be able to map clusters of incidents. For example, FDA personnel can diagram regions of the country where batches of pharmaceuticals have been distributed and then overlay the locations of reported side effects to trace the root cause. It is unclear whether geo-tracking will be the default setting on the app. According to the project requirements, the vendor must "allow [a] registration system for people who want to participate in the nodal network -- willing to send 'locator' information."

The app will be able to handle image attachments, such as X-rays, medical records and electrocardiograms, with an ultimate capacity of up to 4 million reports annually.

The winning contractor will have to ensure the app is available at all appropriate online marketplaces, such as Apple's App Store, and that it appears at the top of search results under a variety of keywords.

Threatwatch Alert

Thousands of cyber attacks occur each day

See the latest threats

JOIN THE DISCUSSION

Close [ x ] More from Nextgov
 
 

Thank you for subscribing to newsletters from Nextgov.com.
We think these reports might interest you:

  • It’s Time for the Federal Government to Embrace Wireless and Mobility

    The United States has turned a corner on the adoption of mobile phones, tablets and other smart devices, outpacing traditional desktop and laptop sales by a wide margin. This issue brief discusses the state of wireless and mobility in federal government and outlines why now is the time to embrace these technologies in government.

    View
  • Featured Content from RSA Conference: Dissed by NIST

    Learn more about the latest draft of the U.S. National Institute of Standards and Technology guidance document on authentication and lifecycle management.

    View
  • A New Security Architecture for Federal Networks

    Federal government networks are under constant attack, and the number of those attacks is increasing. This issue brief discusses today's threats and a new model for the future.

    View
  • Going Agile:Revolutionizing Federal Digital Services Delivery

    Here’s one indication that times have changed: Harriet Tubman is going to be the next face of the twenty dollar bill. Another sign of change? The way in which the federal government arrived at that decision.

    View
  • Software-Defined Networking

    So many demands are being placed on federal information technology networks, which must handle vast amounts of data, accommodate voice and video, and cope with a multitude of highly connected devices while keeping government information secure from cyber threats. This issue brief discusses the state of SDN in the federal government and the path forward.

    View
  • The New IP: Moving Government Agencies Toward the Network of The Future

    Federal IT managers are looking to modernize legacy network infrastructures that are taxed by growing demands from mobile devices, video, vast amounts of data, and more. This issue brief discusses the federal government network landscape, as well as market, financial force drivers for network modernization.

    View

When you download a report, your information may be shared with the underwriters of that document.